Cibc World Market Inc. Grows Position in Ventas, Inc. $VTR

Cibc World Market Inc. grew its stake in shares of Ventas, Inc. (NYSE:VTRFree Report) by 49.0% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 269,789 shares of the real estate investment trust’s stock after purchasing an additional 88,738 shares during the period. Cibc World Market Inc. owned approximately 0.06% of Ventas worth $18,883,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in VTR. Caprock Group LLC purchased a new stake in Ventas during the third quarter worth about $898,000. Krilogy Financial LLC acquired a new stake in shares of Ventas during the 3rd quarter valued at approximately $919,000. Profund Advisors LLC lifted its position in shares of Ventas by 14.7% during the 3rd quarter. Profund Advisors LLC now owns 6,112 shares of the real estate investment trust’s stock valued at $428,000 after acquiring an additional 784 shares during the period. ProShare Advisors LLC boosted its stake in shares of Ventas by 3.1% during the 3rd quarter. ProShare Advisors LLC now owns 117,079 shares of the real estate investment trust’s stock worth $8,194,000 after acquiring an additional 3,535 shares in the last quarter. Finally, Smartleaf Asset Management LLC grew its holdings in shares of Ventas by 99.7% in the 3rd quarter. Smartleaf Asset Management LLC now owns 3,164 shares of the real estate investment trust’s stock worth $219,000 after acquiring an additional 1,580 shares during the period. 94.18% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, CEO Debra A. Cafaro sold 41,294 shares of the firm’s stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $79.01, for a total value of $3,262,638.94. Following the sale, the chief executive officer directly owned 1,145,695 shares of the company’s stock, valued at approximately $90,521,361.95. This trade represents a 3.48% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Peter J. Bulgarelli sold 2,771 shares of the business’s stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $80.01, for a total transaction of $221,707.71. Following the completion of the sale, the chief executive officer owned 108,717 shares of the company’s stock, valued at approximately $8,698,447.17. The trade was a 2.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 96,868 shares of company stock worth $7,574,022. 0.80% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

VTR has been the subject of several research reports. Citigroup lifted their price objective on Ventas from $88.00 to $96.00 and gave the stock a “buy” rating in a report on Wednesday. UBS Group reaffirmed a “neutral” rating and set a $85.00 price target on shares of Ventas in a research note on Monday. Weiss Ratings upgraded shares of Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th. KeyCorp raised their target price on shares of Ventas from $85.00 to $90.00 and gave the company an “overweight” rating in a report on Tuesday. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $93.00 target price on shares of Ventas in a research report on Monday. Fourteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $85.38.

View Our Latest Stock Analysis on VTR

Ventas Price Performance

Ventas stock opened at $85.26 on Friday. The stock has a market capitalization of $40.50 billion, a P/E ratio of 157.89, a P/E/G ratio of 2.09 and a beta of 0.77. Ventas, Inc. has a 12-month low of $60.08 and a 12-month high of $87.20. The company has a debt-to-equity ratio of 1.03, a current ratio of 0.67 and a quick ratio of 0.32. The firm’s 50-day moving average is $78.45 and its two-hundred day moving average is $73.68.

Ventas (NYSE:VTRGet Free Report) last announced its earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). The firm had revenue of ($1,229.71) million for the quarter, compared to analyst estimates of $1.53 billion. Ventas had a return on equity of 2.09% and a net margin of 4.31%.The firm’s revenue was up 21.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.81 EPS. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Equities analysts predict that Ventas, Inc. will post 3.4 earnings per share for the current year.

Ventas Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be paid a $0.52 dividend. The ex-dividend date is Tuesday, March 31st. This is an increase from Ventas’s previous quarterly dividend of $0.48. This represents a $2.08 annualized dividend and a yield of 2.4%. Ventas’s payout ratio is currently 355.56%.

Ventas Company Profile

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

Recommended Stories

Institutional Ownership by Quarter for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.